| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/19/2006 | CA2309304C Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals |
| 09/14/2006 | WO2006096270A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/14/2006 | WO2006096030A1 Potassium channel opener having benzofuroindole skeleton |
| 09/14/2006 | WO2006095711A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 09/14/2006 | WO2006095671A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient |
| 09/14/2006 | WO2006095624A1 Protease inhibitor |
| 09/14/2006 | WO2006095183A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | WO2006095009A1 Amido-substituted 6-phenylphenanthridines |
| 09/14/2006 | WO2006094460A1 A medicine for treating cough and asthma and preparation method thereof |
| 09/14/2006 | WO2006094327A1 Pharmaceutical preparation for treating mycobacterial infections |
| 09/14/2006 | WO2006075172A3 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2 |
| 09/14/2006 | US20060205951 New crystal modification of torasemide |
| 09/14/2006 | US20060205806 Synergistic combination |
| 09/14/2006 | US20060205801 Crystal and process for producing the same |
| 09/14/2006 | US20060205794 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant |
| 09/14/2006 | US20060205790 Medicinal arylethanolamine compounds |
| 09/14/2006 | US20060205770 Acid addition salts such as (-)-(3R)-quinuclidin-3-yl(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate (-)-(2S,3S)-tartrate; for treatment of various M3 receptor-mediated diseases such as urinary incontinence, respiratory diseases such as chronic obstructive pulmonary disease |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205758 Method for reducing the mortality rate |
| 09/14/2006 | US20060205756 Antitussives |
| 09/14/2006 | US20060205749 Remedy and/or preventive for lung diseases |
| 09/14/2006 | US20060205745 Microcrystal |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | CA2601980A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | CA2600636A1 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| 09/14/2006 | CA2599872A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | CA2599778A1 Use of hydroxy tetrahydro-naphtalene derivates for the treatment of respiratory diseases |
| 09/14/2006 | CA2599368A1 Amido-substituted 6-phenylphenanthridines |
| 09/14/2006 | CA2596830A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/13/2006 | EP1700858A1 Salts of a quinuclidine derivative as muscarinic M3 receptor antagonists |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1699803A1 Novel compounds |
| 09/13/2006 | EP1699791A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 09/13/2006 | EP1699495A2 Conjugates of angiotensin ii and an imaging moiety |
| 09/13/2006 | EP1699467A1 Aminoglycoside antibiotics for use as vap-1/ssao inhibitors |
| 09/13/2006 | EP1699456A1 Use of macrolides for treating or preventing airflow obstruction |
| 09/13/2006 | EP1699451A2 Use of at least one effector of glutathione metabolism, together with alpha-liponic acid for the treatment of lung deseases |
| 09/13/2006 | EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1487424B1 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1331939B1 Murraya koenigii extracts for treating asthma |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1274406B1 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1079807B1 Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832948A 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1830998A Total extractives of steroid saponin, prepn. method and application thereof |
| 09/13/2006 | CN1830482A Chinese medicinal composition and application for treating child pneumonia for treating |
| 09/13/2006 | CN1830471A Application of medicinal composition containing epimedium and morinda root in preparation of medicine for treating and preventing rhinallergosis |
| 09/13/2006 | CN1830470A Aerosol and its preparation method |
| 09/13/2006 | CN1830449A Medical use of flavine-3-beta galactoside and its preparation |
| 09/13/2006 | CN1830426A New houttuynine sodium bisulfite injection and its preparation method and use |
| 09/13/2006 | CN1830279A Dried orange peel health-care tea |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274685C Benzimidazol derivatives modulate che mokine receptors |
| 09/13/2006 | CN1274667C Cycloalkenone derivative |
| 09/13/2006 | CN1274326C Composite formulation for treating bronchial asthma |
| 09/13/2006 | CN1274325C Nose drop agent for treating common cold and its preparation method |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105553 Thiazolyl amide derivatives |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105520 Alpha 4 integrin antagonists |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105189 Pressing plant roots or stems, then purification of the liquids, mixing ethanol, storing in refrigerators and filtering, to obtain plant extracts used for prophylaxis of respiratory system disorders; solvent extraction |
| 09/08/2006 | WO2006094134A2 Kim-1 antibodies for treatment of th2-mediated conditions |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093267A1 Fermentation composition having immunomodulating effect |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006092893A1 Enterokinesis promoting compound |
| 09/08/2006 | WO2006092579A1 Microcrystalline ( 5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid |